LIXT – lixte biotechnology holdings, inc. (US:NASDAQ)
Stock Stats
News
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3
LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans
Lixte Biotechnology (NASDAQ:LIXT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT) [Yahoo! Finance]
Form 25-NSE/A LIXTE BIOTECHNOLOGY HOLD Filed by: Nasdaq Stock Market LLC
Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Nov 25
Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Sep 30
Form DEFA14A LIXTE BIOTECHNOLOGY HOLD
Form DEF 14A LIXTE BIOTECHNOLOGY HOLD For: Oct 27
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.